APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models

[1]  P. F. Copenhaver,et al.  Role of APP Interactions with Heterotrimeric G Proteins: Physiological Functions and Pathological Consequences , 2017, Front. Mol. Neurosci..

[2]  T. Saido,et al.  Calpain Activation in Alzheimer's Model Mice Is an Artifact of APP and Presenilin Overexpression , 2016, The Journal of Neuroscience.

[3]  M. Boccia,et al.  Reconsolidation-induced memory persistence: Participation of late phase hippocampal ERK activation , 2016, Neurobiology of Learning and Memory.

[4]  N. Inestrosa,et al.  Wnt-5a/Frizzled9 Receptor Signaling through the Gαo-Gβγ Complex Regulates Dendritic Spine Formation* , 2016, The Journal of Biological Chemistry.

[5]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[6]  Susanne Schoch,et al.  Dendritic Structural Degeneration Is Functionally Linked to Cellular Hyperexcitability in a Mouse Model of Alzheimer’s Disease , 2014, Neuron.

[7]  F. Schmitt,et al.  Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[8]  D. Kögel,et al.  Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway , 2014, Cell Death and Disease.

[9]  E. Isacoff,et al.  APP homodimers transduce an amyloid-β-mediated increase in release probability at excitatory synapses. , 2014, Cell reports.

[10]  S. Itohara,et al.  Single App knock-in mouse models of Alzheimer's disease , 2014, Nature Neuroscience.

[11]  J. Viña,et al.  Aβ and tau toxicities in Alzheimer’s are linked via oxidative stress-induced p38 activation: Protective role of vitamin E , 2014, Redox biology.

[12]  G. Morfini,et al.  Amyloid β precursor protein as a molecular target for amyloid β–induced neuronal degeneration in Alzheimer's disease , 2013, Neurobiology of Aging.

[13]  P. F. Copenhaver,et al.  Amyloid Precursor Proteins Interact with the Heterotrimeric G Protein Go in the Control of Neuronal Migration , 2013, The Journal of Neuroscience.

[14]  Nick C Fox,et al.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.

[15]  K. Jellinger,et al.  Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.

[16]  E. Giralt,et al.  Direct-reversible binding of small molecules to G protein βγ subunits. , 2011, Biochimica et biophysica acta.

[17]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[18]  Daniel Raimunda,et al.  Secreted amyloid precursor protein and holo‐APP bind amyloid β through distinct domains eliciting different toxic responses on hippocampal neurons , 2010, Journal of neuroscience research.

[19]  G. D. Paolo,et al.  Faculty Opinions recommendation of Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. , 2010 .

[20]  E. Masliah,et al.  Interactions between the amyloid precursor protein C‐terminal domain and G proteins mediate calcium dysregulation and amyloid β toxicity in Alzheimer’s disease , 2009, The FEBS journal.

[21]  A. Smrcka,et al.  Small Molecule Disruption of G Protein βγ Subunit Signaling Inhibits Neutrophil Chemotaxis and Inflammation , 2008, Molecular Pharmacology.

[22]  Joseph P. Huston,et al.  The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents , 2007, Neuroscience & Biobehavioral Reviews.

[23]  Verónica de la Fuente,et al.  Activation of Hippocampal Nuclear Factor-κB by Retrieval Is Required for Memory Reconsolidation , 2007, The Journal of Neuroscience.

[24]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[25]  M. Staufenbiel,et al.  Phosphorylation of Actin-Depolymerizing Factor/Cofilin by LIM-Kinase Mediates Amyloid β-Induced Degeneration: A Potential Mechanism of Neuronal Dystrophy in Alzheimer's Disease , 2006, The Journal of Neuroscience.

[26]  D. Bredesen,et al.  Aβ induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597–624) , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  J. Busciglio,et al.  Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons , 2006, The Journal of Neuroscience.

[28]  M. Boccia,et al.  Post-retrieval effects of icv infusions of hemicholinium in mice are dependent on the age of the original memory. , 2006, Learning & memory.

[29]  Steven Mennerick,et al.  Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo , 2005, Neuron.

[30]  M. Boccia,et al.  Memory consolidation and reconsolidation of an inhibitory avoidance response in mice: effects of i.c.v. injections of hemicholinium-3 , 2004, Neuroscience.

[31]  T. Patel,et al.  Single Transmembrane Spanning Heterotrimeric G Protein-Coupled Receptors and Their Signaling Cascades , 2004, Pharmacological Reviews.

[32]  J. Busciglio,et al.  Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid β precursor protein , 2004, Neurobiology of Disease.

[33]  I. Nishimoto,et al.  Characterization of V642I‐AβPP‐induced cytotoxicity in primary neurons , 2004, Journal of neuroscience research.

[34]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[35]  K. Neve,et al.  DNA Synthesis and Neuronal Apoptosis Caused by Familial Alzheimer Disease Mutants of the Amyloid Precursor Protein Are Mediated by the p21 Activated Kinase PAK3 , 2003, The Journal of Neuroscience.

[36]  Judianne Davis,et al.  Localization of a Fibrillar Amyloid β-Protein Binding Domain on Its Precursor* , 2002, The Journal of Biological Chemistry.

[37]  L. K. Baker,et al.  Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability* , 2002, The Journal of Biological Chemistry.

[38]  M. Vitek,et al.  Tau is essential to β-amyloid-induced neurotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[40]  J. Gutkind,et al.  G-protein-coupled receptors and signaling networks: emerging paradigms. , 2001, Trends in pharmacological sciences.

[41]  George Perry,et al.  Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle‐Related Events in Alzheimer Disease , 2000 .

[42]  W. Blackstock,et al.  Phosphorylation Sites on Tau Identified by Nanoelectrospray Mass Spectrometry , 2000, Journal of neurochemistry.

[43]  D R Flower,et al.  Modelling G-protein-coupled receptors for drug design. , 1999, Biochimica et biophysica acta.

[44]  Dominic M. Walsh,et al.  Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons , 1999, The Journal of Neuroscience.

[45]  I. Nishimoto,et al.  G protein βγ complex‐mediated apoptosis by familial Alzheimer's disease mutant of APP , 1997 .

[46]  T. Katada,et al.  Intrinsic signaling function of APP as a novel target of three V642 mutations linked to familial Alzheimer's disease. , 1996, The EMBO journal.

[47]  S. Takeda,et al.  Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait‐linked phenotype. , 1996, The EMBO journal.

[48]  B. Yankner,et al.  β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding , 1995, Neuron.

[49]  I. Nishimoto,et al.  Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go , 1993, Nature.

[50]  V. Lee,et al.  Immunological and conformational characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's disease , 1992 .

[51]  P. Davies,et al.  Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. , 1992, The Journal of biological chemistry.

[52]  P. Cras,et al.  Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Boccia,et al.  Decrease of ERK/MAPK overactivation in prefrontal cortex reverses early memory deficit in a mouse model of Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[54]  A. Anel,et al.  Amyloid-precursor protein mediates neuronal toxicity of amyloid through Go protein activation , 2009 .

[55]  A. Smrcka,et al.  Small molecule disruption of G protein beta gamma subunit signaling inhibits neutrophil chemotaxis and inflammation. , 2008, Molecular pharmacology.

[56]  Verónica de la Fuente,et al.  Activation of hippocampal nuclear factor-kappa B by retrieval is required for memory reconsolidation. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[57]  David M Holtzman,et al.  Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. , 2005, Neuron.

[58]  Judianne Davis,et al.  Localization of a fibrillar amyloid beta-protein binding domain on its precursor. , 2002, The Journal of biological chemistry.

[59]  M. Vitek,et al.  Tau is essential to beta -amyloid-induced neurotoxicity. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[60]  B. Sommer,et al.  Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. , 2000, Nature neuroscience.

[61]  I. Nishimoto,et al.  G protein betagamma complex-mediated apoptosis by familial Alzheimer's disease mutant of APP. , 1997, The EMBO journal.

[62]  L. Otvos,et al.  Immunological and conformation characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's disease. , 1992, Biochemical and biophysical research communications.